SCHEMBL4428090

SCHEMBL4428090

COc1ccc(C(CCc2ccc(C(F)(F)F)cc2)N[S+]([O-])C(C)(C)C)cn1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 3/20 0.41
MCHR1 Q99705 2/20 0.41
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
KDR P35968 1/20 0.38
TEK Q02763 1/20 0.38
TRPM8 Q7Z2W7 1/20 0.36
ACACB O00763 1/20 0.35
CASR P41180 2/20 0.34
BRS3 P32247 1/20 0.34
PRKAB2 O43741 1/20 0.34
PRKAG1 P54619 1/20 0.34
PRKAA2 P54646 1/20 0.34
PRKAA1 Q13131 1/20 0.34
PRKAG3 Q9UGI9 1/20 0.34
PRKAG2 Q9UGJ0 1/20 0.34
PRKAB1 Q9Y478 1/20 0.34
TMEM97 Q5BJF2 2/20 0.33
PPARD Q03181 1/20 0.33
PPARA Q07869 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4440361 0.84 MEN1 (0.53) KCNH2MEN1KMT2ATMEM97CCR3
SCHEMBL4429764 0.83 CASR (0.41) MEN1KMT2ACASRTMEM97PPARD
SCHEMBL4435446 0.80 MEN1 (0.39) KCNH2MEN1KMT2ACASRTMEM97
SCHEMBL8163235 0.79 KCNH2 (0.51) KCNH2MEN1KMT2ATMEM97
SCHEMBL4428027 0.79 CASR (0.48) MEN1KMT2ACASRTMEM97CCR3
SCHEMBL2320170 0.79 CCR3 (0.42) KCNH2MEN1KMT2ATMEM97CCR3
SCHEMBL3733476 0.77 KDR (0.43) KCNH2MCHR1MEN1KMT2AKDR
SCHEMBL2714766 0.73 EPHX2 (0.40) MEN1KMT2AMAPT
SCHEMBL28399788 0.73 EPHX2 (0.40) MEN1KMT2AMAPT
SCHEMBL2714764 0.73 EPHX2 (0.40) MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2114867-A1 AMINOAMIDES AS OREXIN ANTAGONISTS F. Hoffmann-Roche AG (CH) 2009-11-11 EP disclosed
WO-2008107335-A1 AMINOAMIDES AS OREXIN ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2008-09-12 WO disclosed